Prospective, randomized, double-blind, vehicle controlled, multicenter phase IIb clinical trial of the pore forming protein PRX302 for targeted treatment of symptomatic benign prostatic hyperplasia

Mostafa M. Elhilali, Peter Pommerville, Richard C. Yocum, Rosemina Merchant, Claus Roehrborn, Samuel R. Denmeade

Research output: Contribution to journalArticlepeer-review

46 Scopus citations

Fingerprint

Dive into the research topics of 'Prospective, randomized, double-blind, vehicle controlled, multicenter phase IIb clinical trial of the pore forming protein PRX302 for targeted treatment of symptomatic benign prostatic hyperplasia'. Together they form a unique fingerprint.

Medicine & Life Sciences